Brief: Radiopharm Theranostics Agreed Commercial Terms For Services In Signed Letter Of Intent With Genesiscare
23/03/2022 01:15
March 23 (Reuters) - Radiopharm Theranostics Ltd RAD.AX :
* AGREED COMMERCIAL TERMS FOR SERVICES IN SIGNED LETTER OF
INTENT
WITH GENESISCARE
* SIGNS LOI WITH GENESISCARE TO START FIRST TRIAL IN
AUSTRALIA
Source text for Eikon: ID:nASX9NXvqf
Further company coverage: RAD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%